Legend Biotech Corporatio... (LEGN)
NASDAQ: LEGN
· Real-Time Price · USD
37.47
-0.24 (-0.64%)
At close: Aug 15, 2025, 3:59 PM
37.50
0.09%
After-hours: Aug 15, 2025, 06:06 PM EDT
Legend Biotech Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 266.66M | 441.7M | 286.75M | 459.28M | 201.25M | 897.93M | 1.28B | 963.47M | 1.23B | 660.05M | 786.03M | 786.03M | 379.78M | 377.79M | 688.94M | 338.33M | 488.21M | 412.3M |
Short-Term Investments | 700.98M | 563.68M | 835.93M | 753.12M | 1.09B | 404.81M | 31M | 460.37M | 281.57M | 190.07M | 239.62M | 54.02M | 403.33M | 413.47M | 193.46M | 297.6M | 204.49M | 50M |
Long-Term Investments | n/a | n/a | 4.36M | 4.51M | 4.4M | 4.39M | 4.65M | 4.27M | 4.21M | 4.37M | 395K | n/a | 4.47M | 4.73M | 4.71M | n/a | n/a | n/a |
Other Long-Term Assets | 204.31M | 5.58M | 6.06M | 1.93M | 146.15M | 167.76M | 152.42M | 1.53M | 1.41M | 94.61M | 1.49M | -164.17M | 31.91M | 4.91M | 5.15M | 4.57M | 4.88M | 3.98M |
Receivables | 229M | 166.85M | 124.89M | 103.98M | 101.38M | 77.96M | 157.06M | 49.69M | 62.9M | 56K | 278K | 278K | 461K | 50.45M | 50.41M | 1.5M | 15M | n/a |
Inventory | 35.59M | 30.93M | 23.9M | 23.55M | 18.87M | 22.15M | 19.43M | 18.01M | 15.2M | 12.18M | 10.35M | 10.35M | 8.16M | 2.9M | 1.75M | 1.63M | 1.7M | 2.1M |
Other Current Assets | n/a | 70K | 70K | 583K | 431K | 359K | 357K | 356K | 1.25M | 1.28M | 45.51M | 248.44M | 2.07M | 1.45M | 8.48M | 456K | 256K | 256K |
Total Current Assets | 1.25B | 1.22B | 1.28B | 1.35B | 1.42B | 1.41B | 1.5B | 1.51B | 1.61B | 915.4M | 1.1B | 1.1B | 835.95M | 862.71M | 948.75M | 653.36M | 720.83M | 475.07M |
Property-Plant & Equipment | 233.6M | 206.58M | 201.59M | 203.86M | 220.03M | 186.02M | 189.68M | 184.73M | 190.54M | 192.7M | 161.67M | 160.76M | 145.79M | 163.66M | 155.08M | 150.4M | 144.72M | 132.12M |
Goodwill & Intangibles | 2.14M | 184.69M | 174.22M | 175.49M | 2.77M | 169.5M | 155.28M | 140.01M | 2.46M | 2.29M | 68.69M | 3.41M | 4.62M | 4.52M | 4.68M | 5.43M | 4.68M | 4.08M |
Total Long-Term Assets | 440.05M | 396.86M | 386.24M | 385.79M | 373.35M | 361.31M | 350.81M | 330.54M | 317.8M | 293.96M | 231.84M | 164.17M | 186.8M | 177.81M | 169.62M | 160.4M | 154.29M | 140.18M |
Total Assets | 1.69B | 1.62B | 1.67B | 1.74B | 1.8B | 1.78B | 1.85B | 1.84B | 1.93B | 1.21B | 1.33B | 1.33B | 1.02B | 1.04B | 1.12B | 813.76M | 875.13M | 615.25M |
Account Payables | 75.36M | 58.14M | 37.19M | 26.91M | 39.49M | 39.48M | 20.16M | 17.17M | 21.54M | 29.81M | 32.89M | 32.89M | 12.24M | 9.71M | 7.04M | 11.59M | 11M | 9.65M |
Deferred Revenue | 33.18M | 40.07M | 46.87M | 63.72M | 75.39M | 63.25M | 53.01M | 630K | 435K | 457K | 451K | n/a | 315K | 65.88M | 60.95M | 56.12M | 56.44M | 54.74M |
Short-Term Debt | 5.91M | 5.34M | 4.79M | 4.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 139.49M | -5.34M | 118.73M | -4.34M | 38.88M | 28.5M | n/a | 30.51M | 42.1M | 203.78M | 239.44M | 264.89M | 245.08M | 214.94M | 166.23M | 206.84M | 192.78M | 80.38M |
Total Current Liabilities | 265.49M | 234.37M | 277.64M | 270.89M | 294.3M | 249.68M | 216.42M | 175.22M | 201.38M | 238.18M | 297.79M | 297.79M | 259.76M | 225.53M | 280.27M | 275.37M | 261.1M | 145.94M |
Long-Term Debt | 310.27M | 305.75M | 301.2M | 296.62M | 291.56M | 286.4M | 281.33M | 275.91M | 270.61M | 265.86M | 260.93M | 260.93M | 189.22M | 126.71M | 120.46M | 70.54M | 17.31M | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | 27K | n/a | 23.14M | 48.02M | 6.88M | 7.19M | 7.86M | 7.89M | -260.93M | 314K | 356K | 244.84M | 991K | 554K | 261.19M |
Total Long-Term Liabilities | 382.01M | 363.53M | 351.96M | 348.82M | 344.88M | 354.71M | 373.51M | 324.48M | 322.25M | 318.02M | 288.86M | 260.93M | 200.36M | 376.42M | 366.89M | 312.53M | 274.11M | 262.86M |
Total Liabilities | 647.5M | 597.9M | 629.61M | 619.72M | 639.18M | 604.38M | 589.93M | 499.7M | 523.63M | 556.2M | 586.65M | 586.65M | 460.11M | 601.95M | 647.16M | 587.9M | 535.21M | 408.8M |
Total Debt | 387.92M | 362.81M | 350.6M | 346.59M | 338.93M | 334.69M | 328.67M | 320.51M | 318.62M | 314.76M | 284.53M | n/a | 195.72M | 129.23M | 122.97M | 73.52M | 20.11M | 3.13M |
Common Stock | 37K | 37K | 37K | 37K | 37K | 36K | 36K | 36K | 36K | 33K | 33K | 33K | 31K | 31K | 31K | 29K | 29K | 27K |
Retained Earnings | n/a | -1.76B | -1.66B | -1.69B | -1.56B | -1.54B | -1.48B | -1.34B | -1.28B | n/a | -966.46M | -966.46M | n/a | n/a | -520.11M | -728.63M | -603.24M | n/a |
Comprehensive Income | n/a | -7.43M | -68.16M | 47.68M | -14.22M | 62.66M | 98.92M | 966K | 1.41B | 653.12M | 14.67M | n/a | 562.6M | 438.53M | 471.18M | 225.84M | 339.89M | 206.42M |
Shareholders Equity | 1.04B | 1.02B | 1.04B | 1.12B | 1.16B | 1.16B | 1.25B | 1.34B | 1.41B | 653.16M | 744.31M | 744.31M | 562.63M | 438.56M | 471.21M | 225.87M | 339.92M | 206.45M |
Total Investments | 700.98M | 563.68M | 840.3M | 757.63M | 1.09B | 409.19M | 35.65M | 464.63M | 285.78M | 194.44M | 239.62M | 54.02M | 407.8M | 418.2M | 198.16M | 297.6M | 204.49M | 50M |